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Statistical adjustment for a measure of
healthy lifestyle doesn’t yield the truth
about hormone therapy
Diana B. Petitti∗1 and Wansu Chen∗2
University of Southern California and Kaiser Permanente Southern California
Abstract: The Women’s Health Initiative randomized clinical trial of hor-
mone therapy found no benefit of hormones in preventive cardiovascular dis-
ease, a finding in striking contrast with a large body of observational re-
search. Understanding whether better methodology and/or statistical adjust-
ment might have prevented the erroneous conclusions of observational research
is important. This is a re-analysis of data from a case-control study examin-
ing the relationship of postmenopausal hormone therapy and the risks of my-
ocardial infarction (MI) and ischemic stroke in which we reported no overall
increase or decrease in the risk of either event. Variables measuring health be-
havior/lifestyle that are not likely to be causally with the risks of MI and stroke
(e.g., sunscreen use) were included in multivariate analysis along with tradi-
tional confounders (age, hypertension, diabetes, smoking, body mass index,
ethnicity, education, prior coronary heart disease for MI and prior stroke/TIA
for stroke) to determine whether adjustment for the health behavior/lifestyle
variables could reproduce or bring the results closer to the findings in a large
and definitive randomized clinical trial of hormone therapy, the Women’s
Health Initiative.
For both MI and stroke, measures of health behavior/lifestyle were associ-
ated with odds ratios (ORs) less than 1.0. Adjustment for traditional cardio-
vascular disease confounders did not alter the magnitude of the ORs for MI or
stroke. Addition of a subset of these variables selected using stepwise regres-
sion to the final MI or stroke models along with the traditional cardiovascular
disease confounders moved the ORs for estrogen and estrogen/progestin use
closer to values observed in the Women Health Initiative clinical trial, but did
not reliably reproduce the clinical trial results for these two endpoints.
1. Background
The Women’s Health Initiative (WHI) clinical trial of hormone therapy is a large
randomized trial whose primary aim was determining whether post-menopausal
hormone therapy prevents coronary heart disease (Rossouw et al. [10] and Ander-
son et al. [1]). The study began in the early 1990’s and published main results in
2002–2004. It involved recruitment and randomization of more than 18,000 post-
menopausal women to hormones or placebo. The WHI found no overall effect, or
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perhaps an increase, in the risk of myocardial infarction (MI) in women assigned
to combined estrogen/progestin (E/P) therapy and no effect of estrogen alone (E)
(Rossouw et al. [10] and Anderson et al. [1]). Prior observational research con-
cluded that the risk of coronary heart disease was reduced by half (Stampfer and
Colditz [12]). Moreover, the risk of stroke was increased for both E and E/P in WHI
(Rossouw et al. [10] and Anderson et al. [1]). Prior observational research found no
effect of hormone therapy on stroke (Psaty et al. [9]).
Publications by Prentice et al. suggest statistical approaches that would have
overcome the discrepancy between the observational research and the clinical trial
(Prentice et al. [7] and Prentice et al. [8]). Reviews of these approaches are mixed
(Petitti and Freedman [5], Freedman and Petitti [3], DeMets [2] and Greenland [4]).
Understanding whether better methodology and/or statistical adjustment might
have prevented the erroneous conclusions made based on the observational research
is important.
We previously published the results of a case-control study in which we esti-
mated the relative risks of myocardial infarction (MI) and stroke in current users of
E and E/P that adjusted for traditional cardiovascular disease confounders—age,
ethnicity, education as a measure of socioeconomic status, and factors known to
increase the risk of MI or stroke causally (smoking, diabetes, hypertension, body
mass index), using logistic regression (Petitti et al. [6] and Sidney et al. [11]). The
study neither confirmed nor ruled out a lower risk of MI or stroke in hormone users.
Adjusted estimates of the relative risk of MI and stroke were both, however, less
than 1.0 in current E and EP users compared with never hormone users, a finding
inconsistent with WHI.
This is a re-analysis of data from our case-control study. In the re-analysis, vari-
ables that assess health behaviors/lifestyle were added to the multivariate analysis
along with the traditional confounders to determine whether adjustment for these
variables, as a marker for healthy lifestyle, could reproduce or bring the results
closer to the findings in the Women’s Health Initiative for stroke and MI. Some of
the health behavior/lifestyle variables were chosen specifically because they were
NOT likely to be causally related to MI or stroke and whose relationship with these
conditions would be expected to be non-causal.
2. Methods
2.1. Overview
Study methods and results examining the association of hormone therapy with the
risk of stroke and MI after adjustment for traditional confounders are described in
detail in two prior publications (Petitti et al. [6] and Sidney et al. [11]). Briefly, an
attempt was made to identify all fatal and non-fatal strokes and MIs in women age
45-74 years in 10 medical centers of the Kaiser Permanente Medical Care Program,
Northern California region, during the period, November, 1991 – November, 1994.
A standard protocol was used to define stroke and subclassify it by type. Our
re-analysis includes only strokes classified as ischemic.
For each case, an attempt was made to interview one control, matched on year of
birth and facility of usual care. Out of 550 ischemic stroke cases and 685 MI cases,
we were able to obtain 349 stroke case/controls sets and 438 MI case/control sets
for analysis, after exclusions described in the Analysis section.
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2.2. Information
Eligible cases and controls were interviewed in-person by trained interviewers using
a standardized instrument. Interview questions were asked relative to an index date,
which was the date of symptom onset for cases and the same date for her matched
control. If a case had died or was unable to communicate verbally, an attempt was
made to interview a proxy, but proxy responses are excluded from this analysis.
Hypertension was defined as a “yes” to a question about use of medication for
high blood pressure. Diabetes was defined as a “yes” to a question asking about
use of insulin or pills for diabetes. Women who stated that they had been told by
a physician that they had a high cholesterol level were classified as having hyper-
cholesterolemia (high cholesterol level was not used as a covariate in the original
analysis). A study subject was defined as a nonsmoker if she answered “no” to the
question, “Have you ever smoked cigarettes?” If she answered “yes” to this ques-
tion, she was categorized as a current regular smoker on the basis of her answer to
the question, “On [index date] were you still smoking regularly?” (Regularly means
at least 5 cigarettes per week, almost every week). Body mass index was calculated
from self-reported height and weight.
The questions asked about health behavior/lifestyle spanned a range of activities
and behaviors that people believe may improve their health. We sought especially
to identify questions about activities and behaviors that were NOT related causally
to cardiovascular disease risk. Women were asked, “Do you do the following to try
to improve your health?” This was followed by the trained interviewer reading each
behavior with a query for a “yes” or “no” response.
2.3. Analysis
We defined current hormone use as “yes” for hysterectomized women who used
E within 1 month of the index date; current hormone use was defined as “yes”
for non-hysterectomized women who used E/P within 1 month of the index date;
and “no” otherwise. Excluded from the analysis were pre-menopausal women and
hysterectomized women who used EP, non-hysterectomized women who used E, and
users of progestin only within 1 month of the index. All exclusions were applied in
the same way to cases and controls. These exclusions and definitions are the same
as in our prior published analyses.
The odds ratio (OR) was used to estimate the relative risk of MI and stroke.
The multivariate analysis used conditional logistic regression analysis. Ninety-five
percent confidence intervals (CI) were calculated for OR estimates.
We first calculated age-adjusted ORs for MI and stroke in relation to the tradi-
tional vascular disease risk factors and in relation to use of E and E/P separately
in hysterectomized and non-hysterectomized women. We then examined ORs for
stroke and MI in relation to each of the lifestyle/behavior questions adjusting first
for age only and then for age and the traditional cardiovascular disease confounders,
also separately in women with and without a hysterectomy. Last, we used stepwise
logistic regression to screen the list of behavior/lifestyle variables and select only
those meeting a significance level of 0.2 or lower for both entering and staying in
the models while forcing all the traditional vascular disease risk factors to stay in
the model. Thus, only those behavior/lifestyle variables deemed important statisti-
cally to the outcomes are included (separate analyses for women with and without
a hysterectomy).
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3. Results
Although we attempted to reproduce the study samples using the same exclusion
criteria described in the two publications, we were unable to gather six stroke
case/control sets and four MI case/control sets. Tables 1 and 2 show the charac-
teristics of non-hysterectomized and hysterectomized cases and controls and age-
adjusted ORs and 95% C.I.s for MI and stroke in relation to the traditional con-
founders and current use of E/P (for non-hysterectomized women) and E only (for
hysterectomized women). The traditional cardiovascular disease risk factors show
expected associations with the risk of MI and stroke.
Tables 3 and 4 show ORs and 95% C.I.s for stroke and MI in relation to each of
the variables that measure health behavior in non-hysterectomized and hysterec-
tomized women adjusting for age and then for age and the traditional confounders.
For almost all of the health behavior questions, age-adjusted ORs for both stroke
and MI in women who responded “yes” to the question are lower than 1.0 in both
non-hysterectomized and hysterectomized women. Adjustment for the traditional
cardiovascular disease risk factors in addition to age does not change the magnitude
of the OR for any variable by much, although the C.I.s often include 1.0.
The fully adjusted ORs for MI in non-hysterectomized women who stated they
regularly used sunblock or sunscreen (adjusted OR 0.3; 95% C.I. 0.2–0.5) or who
stated they were trying to cut down on alcohol use (adjusted OR 0.4; 95% C.I.
0.2–0.7) are of particular note. The fully adjusted OR for stroke in hysterectomized
women who stated they regularly used sunblock or sunscreen (OR 0.4; 95% C.I.
0.2–0.9) is also noteworthy.
The ORs in women who answered yes to the behavior questions are further from
1.0 for MI than for stroke in both non-hysterectomized and hysterectomized women
(Tables 3–4). The adjustment for the traditional confounders changes the estimates
less for MI than for stroke in both non-hysterectomized and hysterectomized women.
Table 5 shows the results of models assessing the ORs for stroke and MI in
relation to current use of E and E/P after adjustment. The ORs for stroke reported
in the previous publication were based on the sample that includes women with
hysterectomy who used E/P and women without hysterectomy who used E and
therefore are not exactly the same as the results in this re-analysis. The ORs were
estimated for current use of E and E/P after adjusting for age only, for age and
the traditional confounders, and then for age and the traditional confounders plus
the behavior/lifestyle variables that were selected using the stepwise regression
procedure. Estimates for the risk of coronary heart disease and stroke from WHI
in non-hysterectomized users of E/P and hysterecomized users of E are shown
for comparison. Adjustment for the behavior/lifestyle variables in addition to the
traditional confounders results in further changes in the ORs for current use of E and
E/P. However, neither adjustment for the traditional confounders nor adjustment
for the behavior/lifestyle variables in addition to the traditional confounders reliably
reproduces the WHI results considering both disease endpoints and both E and E/P.
4. Discussion
For both MI and stroke, the variables that measured healthy behavior/lifestyle
were associated with ORs less than 1.0 even after adjustment for age. Even after
adjustment for the traditional cardiovascular disease confounders in addition to age,
the ORs for the variables that measured healthy behavior/lifestyle remained mostly
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Table 1
Women without hysterectomy: for demographic and other characteristics, percent of cases and controls and age adjusted odds ratios for myocardial infarction and
stroke for each characteristic
Myocardial infarction Stroke
Cases Controls Cases Controls
Characteristic (N = 189) (N = 199) OR (95% CI) (N = 156) (N = 153) OR (95% CI)
Current E/P, % 20.1 29.7 0.6 (0.4–1.01)∗ 18 24.2 0.7 (0.4–1.2)∗
Treated for hypertension, % 41.3 30 1.6 (1.1–2.5) 49.7 27.5 2.6 (1.6–4.2)
Treated for diabetes, % 22.3 8.1 3.3 (1.8–6.1) 27.1 11.8 2.8 (1.5–5.1)
Body Mass Index
Quartile 1 (lowest) 24.9 30.3 1.0 (ref) 23.8 30.5 1.0 (ref)
Quartile 2 17.8 28.8 0.7 (0.4–1.3) 22.5 24.5 1.2 (0.6–2.3)
Quartile 3 25.4 17.2 1.8 (0.98–3.2) 29.2 23.2 1.6 (0.9–3.1)
Quartile 4 31.9 23.7 1.6 (0.96–2.8) 24.5 21.8 1.4 (0.8–2.7)
Cigarette smoking %
Never 45 50.2 1.0 (ref) 35.3 53.6 1.0 (ref)
Past 21.7 33.7 0.7 (0.5–1.2) 30.1 32 1.5 (0.9–2.5)
Occasional/Current 33.3 16.1 2.5 (1.5–4.3) 34.6 14.4 3.8 (2.1–6.9)
Race/Ethnicity %
White, non-Hispanic 76.8 75.7 1.0 (ref) 66 77.8 1.0 (ref)
Hispanic 8.9 7.1 1.2 (0.6–2.6) 11.1 8.5 1.6 (0.7–3.4)
African-American 5.4 7.6 0.7 (0.3–1.7) 12.4 4.6 3.3 (1.3–8.2)
Asian 5.4 7.6 0.7 (0.3–1.7) 8.5 6.5 1.6 (0.7–3.9)
Other or unknown 3.8 2 1.9 (0.5–6.6) 2 2.6 0.9 (0.2–4.0)
Level of Education %
Less than high school 17.9 11.7 1.0 (ref) 22.2 12.4 1.0 (ref)
High school graduate 35.9 33 0.7 (0.4–1.3) 33.3 31.4 0.6 (0.3–1.2)
Some college or business or technical training 33.2 35.5 0.6 (0.3–1.1) 37.3 34 0.6 (0.3–1.2)
College graduate 13 19.8 0.4 (0.2–0.9) 7.2 22.2 0.2 (0.1–0.4)
History of CHD % 5.3 3.5 1.5 (0.5–4.0) – –
Prior Stroke / TIA % – – 5.1 0.7 8.3 (1.03–67.0)
* Reference group “Never”
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Table 2
Women with hysterectomy: for demographic and other characteristics, percent of cases and controls and age adjusted odds ratios for myocardial infarction and
stroke for each characteristic
Myocardial infarction Stroke
Cases Controls Cases Controls
Characteristic (N = 125) (N = 122) OR (95% CI) (N = 90) (N = 85) OR (95% CI)
Current E, % 68 74.6 0.7 (0.4–1.2)∗ 68.9 74.1 0.7 (0.4–1.4)
Treated for hypertension, % 47.2 34.4 1.7 (1.04–2.9) 46.7 27.1 2.6 (1.4–5.0)
Treated for diabetes, % 25.6 9.8 3.2 (1.5–6.5) 28.1 3.5 10.5 (3.0–36.3)
Body Mass Index
Quartile 1 (lowest) 22.6 24.8 1.0 (ref) 20.6 28.3 1.0 (ref)
Quartile 2 25 32.2 0.9 (0.4–1.7) 30.7 23.5 1.8 (0.8–4.1)
Quartile 3 29 23.2 1.4 (0.7–2.8) 23.9 18.8 1.8 (0.7–4.4)
Quartile 4 23.4 19.8 1.3 (0.6–2.7) 25 29.4 1.2 (0.5–2.7)
Cigarette smoking %
Never 37.6 50 1.0 (ref) 41.1 47 1.0 (ref)
Past 30.4 33.6 1.2 (0.7–2.2) 31.1 41.2 0.9 (0.4–1.7)
Occasional/Current 32 16.4 2.8 (1.4–5.5) 27.8 11.8 2.6 (1.1–6.2)
Race/Ethnicity %
White, non-Hispanic 87.9 82 1.0 (ref) 73.9 84.7 1.0 (ref)
Hispanic 4.9 8.2 0.6 (0.2–1.6) 11.4 4.7 2.7 (0.8–9.1)
African-American 3.2 4.1 0.7 (0.2–2.8) 5.7 3.5 1.8 (0.4–8.0)
Asian 3.2 4.9 0.6 (0.2–2.2) 3.4 3.5 1.1 (0.2–5.5)
Other or unknown 0.8 0.8 0.9 (0.1–14.6) 5.7 3.5 1.8 (0.4–7.8)
Level of Education %
Less than high school 21 14.8 1.0 (ref) 26.1 5.9 1.0 (ref)
High school graduate 37.9 29.5 0.9 (0.4–1.9) 30.7 28.2 0.2 (0.1–0.7)
Some college or business or technical training 29.8 33.6 0.6 (0.3–1.3) 31.8 43.5 0.2 (0.1–0.5)
College graduate 11.3 22.1 0.4 (0.1–0.9) 11.4 22.4 0.1 (0.03–0.4)
History of CHD % 6.4 4.9 1.3 (0.4–3.9) – –
Prior Stroke / TIA % – – 1.1 1.2 1.1 (0.1−19.0)
* Reference group “Never”.
1
4
8
D
.
B
.
P
etitti
a
n
d
W
.
C
h
en
Table 3
Women without hysterectomy: percent of cases and controls who reported the behavior and adjusted odds ratios for myocardial infarction and stroke in women who
reported the behavior
Myocardial infarction Stroke
Adjusted for Adjusted for
traditional Age traditional
Cases Controls Age adjusted confounders1 Cases Controls adjusted confounders2
Health behaviors (N = 189) (N = 199) OR (95% CI) OR (95% CI) (N = 156) (N = 153) (95% CI) OR (95% CI)
Exercise 54.6 69.2 0.5 (0.3–0.8) 0.6 (0.4–0.99) 53.6 69.9 0.5 (0.3–0.8) 0.6 (0.3–1.0)
Try to eat more foods containing fiber 75 85.4 0.5 (0.3–0.9) 0.6 (0.3–0.97) 73.7 86.3 0.4 (0.2–0.8) 0.6 (0.3–1.1)
Try to eat foods low in fat 68.1 84.3 0.4 (0.2–0.7) 0.4 (0.2–0.7) 76.5 88.2 0.4 (0.2–0.8) 0.5 (0.3–1.1)
Eat more olive oil 26.6 34 0.7 (0.5–1.1) 0.7 (0.5–1.2) 29.4 37.9 0.7 (0.4–1.1) 0.8 (0.5–1.5)
Use sunblock or sunscreen 26 50.8 0.3 (0.2–0.5) 0.3 (0.2–0.5) 32 44.4 0.6 (0.4–0.9) 0.8 (0.4–1.3)
Cut down on alcohol consumption 11.9 25.3 0.4 (0.2–0.7) 0.4 (0.2–0.7) 20.9 22.9 0.9 (0.5–1.6) 0.7 (0.4–1.3)
Cut down on caffeine 33 34.3 0.9 (0.6–1.4) 0.9 (0.6–1.5) 29.6 34 0.8 (0.5–1.3) 0.8 (0.4–1.3)
Take vitamin supplements 47.6 55.6 0.7 (0.5–1.1) 0.8 (0.5–1.3) 48.7 60.8 0.6 (0.4–0.96) 0.8 (0.4–1.3)
Meditate or use other 22.2 38.4 0.5 (0.3–0.7) 0.5 (0.3–0.9) 22.2 35.3 0.5 (0.3–0.9) 0.6 (0.3–1.03)
technique to reduce stress
Cut down on red meat 56.2 72.7 0.5 (0.3–0.7) 0.5 (0.3–0.8) 62.1 71.9 0.6 (0.4–1.03) 0.6 (0.3–0.97)
Take calcium supplement 32.6 42.9 0.6 (0.4–0.98) 0.9 (0.5–1.4) 30.5 51.3 0.4 (0.3–0.7) 0.5 (0.3–0.9)
Take fish oil supplement 4.3 8.6 0.5 (0.2–1.2) 0.4 (0.2–1.1) 5.2 6.5 0.8 (0.3–2.1) 0.7 (0.2–2.1)
Any other thing to try to stay healthy 23.2 24.2 0.9 (0.6–1.5) 1.1 (0.7–1.8) 21.6 23.5 0.9 (0.5–1.5) 0.9 (0.5–1.7)
1age, hypertension, diabetes, body mass index (quartiles), smoking, race and ethnicity, level of education and history of coronary heart disease.
2age, hypertension, diabetes, body mass index (quartiles), smoking, race and ethnicity, level of education and history of stroke/TIA.
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Table 4
Women with hysterectomy: percent of cases and controls who reported the behavior and adjusted odds ratios for myocardial infarction and stroke in women who
reported the behavior
Myocardial infarction Stroke
Adjusted for Adjusted for
traditional Age traditional
Cases Controls Age adjusted confounders1 Cases Controls adjusted confounders2
Health behaviors (N = 125) (N = 122) OR (95% CI) OR (95% CI) (N = 90) (N = 85) (95% CI) OR (95% CI)
Exercise 54.5 69.7 0.5 (0.3–0.9) 0.6 (0.3–1.06) 62.1 78.8 0.4 (0.2–0.9) 0.5 (0.2–1.2)
Try to eat more foods containing fiber 81.5 85.3 0.8 (0.4–1.5) 0.8 (0.4–1.7) 80.7 89.4 0.5 (0.2–1.2) 0.5 (0.2–1.6)
Try to eat foods low in fat 82.3 86.1 0.8 (0.4–1.5) 0.9 (0.4–1.8) 83 89.4 0.6 (0.2–1.5) 0.5 (0.2–1.5)
Eat more olive oil 29 32.5 0.8 (0.5–1.5) 1.0 (0.5–1.9) 30 43.5 0.6 (0.3–1.04) 0.8 (0.4–1.8)
Use sunblock or sunscreen 37.1 48.4 0.6 (0.4–1.04) 0.8 (0.4–1.4) 27.3 57.7 0.3 (0.1–0.5) 0.4 (0.2–0.9)
Cut down on alcohol consumption 22.6 30.3 0.7 (0.4–1.2) 0.6 (0.3–1.2) 18.2 25.9 0.6 (0.3–1.3) 0.7 (0.3–1.7)
Cut down on caffeine 32 45.1 0.6 (0.3–0.96) 0.6 (0.3–1.00) 31.8 37.7 0.8 (0.4–1.5) 0.9 (0.4–2.0)
Take vitamin supplements 50.8 61.5 0.6 (0.4–1.08) 0.6 (0.4–1.08) 54.6 64.7 0.7 (0.4–1.2) 0.7 (0.3–1.5)
Meditate or use other 28.2 41.8 0.5 (0.3–0.9) 0.5 (0.3–0.9) 29.9 47.1 0.5 (0.3–0.9) 0.5 (0.2–1.04)
technique to reduce stress
Cut down on red meat 63.7 74.6 0.6 (0.3–1.04) 0.5 (0.3–0.97) 67.1 78.8 0.6 (0.3–1.1) 0.5 (0.2–1.1)
Take calcium supplement 39.5 51.6 0.6 (0.4–1.02) 0.8 (0.5–1.4) 44.3 47.1 0.9 (0.5–1.7) 1.1 (0.5–2.2)
Take fish oil supplement 4.8 7.4 0.6 (0.2–1.9) 0.9 (0.3–3.1) 6.8 7.1 1.0 (0.3–3.2) 0.9 (0.2–3.7)
Any other thing to try to stay healthy 24.2 23.1 1.1 (0.6–1.9) 1.2 (0.6–2.4) 27.6 29.4 0.9 (0.5–1.8) 1.1 (0.5–2.6)
1 age, hypertension, diabetes, body mass index (quartiles), smoking, race and ethnicity, level of education and history of coronary heart disease.
2 age, hypertension, diabetes, body mass index (quartiles), smoking, race and ethnicity, level of education and history of stroke/TIA.
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Table 5
Odds ratios for myocardial infarction and ischemic stroke in current users of estrogen alone or estrogen/progestin after various adjustments and comparison with
women’s health initiative clinical trial results
Women without hysterectomy / Women with hysterectomy /
estrogen plus progestin estrogen only
Myocardial infarction Ischemic stroke Myocardial infarction Ischemic stroke
Adjustment odds ratio (95% C.I.) odds ratio (95% C.I.) odds ratio (95% C.I.) odds ratio (95% C.I.)
Current analysis
Age only 0.62 (0.38–1.007) 0.71 (0.41–1.24) 0.71 (0.41–1.25) 0.72 (0.37–1.42)
Age and traditional confounders1 0.91 (0.52–1.58) 0.85 (0.43–1.66) 0.96 (0.50–1.82) 1.17 (0.48–2.90)
Age, traditional confounders1
+ health behavior variables
selected using stepwise regression 1.13 (0.62–2.06)2 1.00 (0.50–2.01)3 1.04 (0.52–2.00)4 1.01 (0.40–2.54)5
Women’s Health Initiative clinical trial 1.32 (1.02–1.72)6 1.41 (1.07–1.85)7 0.89 (0.70–1.12)6 1.39 (1.10–1.77)7
1Age, hypertension, diabetes, body mass index, smoking, race and ethnicity, level of education, history of coronary heart disease for myocardial infarction and history
of stroke for stroke.
2Try to eat more foods low in fat; use sunblock or sunscreen; cut down on alcohol consumption; cut down on caffeine; meditate or use other technique to reduce
stress; cut down red meat; take fish oil supplement.
3Exercise; cut down on red meat; take calcium supplement.
4Cut down on caffeine; take vitamin supplements; meditate or use other technique to reduce stress; cut down red meat.
5Use sunblock or sunscreen; meditate or use other technique to reduce stress.
6Non-fatal MI; nominal confidence interval.
7Fatal plus non-fatal; nominal confidence interval.
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less than 1.0. Of particular note is the persistence of the association of sunscreen use
with lower risk of MI and stroke even after adjustment for confounders. It is highly
unlikely that sunscreen use prevents MI or stroke. We chose to query women in
the study about this behavior precisely because there was no immediately plausible
direct causal pathway between sunscreen use and these cardiovascular endpoints.
We hypothesized a priori that sunscreen use and the other health behaviors would
be markers of a “healthy lifestyle” and that adjustment for a measure of healthy
lifestyle would improve inferences about the effect of hormone therapy on MI and
stroke.
Our findings with regard to sunscreen use shows that a strategy in which non-
causal variables are systematically measured in appropriate models might improve
inferences deriving from observational research. Education, social status, and in-
come are examples of variables that epidemiologists frequently consider as con-
founders even though their relationship with disease is seldom causal. Rather, the
variables “capture” the causal associations of factors associated with the exposure
that get “mixed” with the true effect of the exposure.
Our analysis does not include some variables that are measurable (family history
of heart disease, untreated hypertension) and whose inclusion might further change
the estimates. We did not include interaction terms in the models and this might
also have brought the data closer to WHI. Where to stop when adjusting is generally
left to the researcher’s judgment. When the “truth” is known, it may be possible to
find the “truth.” The problems arise when the researcher seeks the truth through
modeling.
In the current analysis, adjustment for the behaviors with the strongest associ-
ation with the given vascular endpoint moved the ORs estimates for current E and
E/P closer to values observed in the WHI. Of course, we know that the adjustment
moved the ORs in the “right” direction only because of the clinical trial. Even with
the adjustment for healthy behavior/lifestyle in addition to adjustment for known
confounders, we were unable to reproduce completely the clinical trial results.
Acknowledgments. Thanks to Steve Sidney who was a co-investigator in the
main study.
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